Product: mitoXANTRONE Injection USP (concentrate), 20 mg/10 mL (2 mg/mL), 10 mL Multiple Dose Vial packaged in a carton, Rx only, Teva Parenteral Medicines, Inc., Irvine, CA  92618, NDC 0703-4685-01.
Reason for recall: Failed Impurities/Degradation Specifications: High out of specification results for Impurity D.
Recall initiated: 20160531
Status: Terminated
Classification: Class III
Recall type: Voluntary: Firm initiated